Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease

The identification of the molecular drivers of cancer by sequencing is the backbone of precision medicine and the basis of personalized therapy; however, biopsies of primary tumors provide only a snapshot of the evolution of the disease and may miss potential therapeutic targets, especially in the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Timothy M., Johnson-Camacho, Katherine, Peto, Myron, Wang, Nicholas J., Macey, Tara A., Korkola, James E., Koppie, Theresa M., Corless, Christopher L., Gray, Joe W., Spellman, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552879/
https://www.ncbi.nlm.nih.gov/pubmed/26317216
http://dx.doi.org/10.1371/journal.pone.0136407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552879/
https://www.ncbi.nlm.nih.gov/pubmed/26317216
http://dx.doi.org/10.1371/journal.pone.0136407

Ejemplares similares